MOSCOW (Reuters) – Russia has sent documents to Indian regulators for the registration of its Sputnik M vaccine for use in children aged 12-17, the Russian Direct Investment Fund (RDIF) said on Monday.
Russia’s health ministry registered Sputnik M in late November and has said shots are expected to be available at the end of December.
(Reporting by Polina Nikolskaya; Writing by Alexander Marrow; Editing by Edmund Blair)
